Healthy Participants Needed for Lung Inflammation Study
Trial Objectives
Inflammation in the lungs is tied to a number of diseases, including pneumonia and acute respiratory distress syndrome (ARDS). Researchers want to better understand how the lungs heal after patients have recovered from these conditions by studying the involvement of immune cells called macrophages.
Volunteers in this study will be randomly assigned to one of two groups. The first group will receive a treatment that will stimulate the immune cells in the lung and then receive a nasal brushing and bronchoscopy. The second group will receive the nasal brushing and bronchoscopy only. Researchers will use the information collected to develop therapies that can help the lungs heal more effectively.
Who Can Participate
Adults 18-50 with no prior history of lung or systemic diseases.
Age: 18-50 Gender: Any
Estimated Time Commitment
Three study visits, with the first visit lasting 1-2 hours and last two lasting about 6-8 hours each.
Payment & Reimbursement
Payment: Provided
Travel Reimbursement: Not Available
Trial Contact
For more information, contact:
Beatrice Kwarteng
303.398.1553
Trial Location
National Jewish Main Campus, Denver, CO
Trial Sponsors
National Institutes of Health (NIH)
Principal Investigators
Kara Mould, MD, MPH
Co-Investigators
William J. Janssen, MD